Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
出版年份 2021 全文链接
标题
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
作者
关键词
-
出版物
Cancers
Volume 13, Issue 7, Pages 1511
出版商
MDPI AG
发表日期
2021-03-26
DOI
10.3390/cancers13071511
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
- (2020) Rasmus Siersbæk et al. CANCER CELL
- Interleukin-6 Expression by Hypothalamic Microglia in Multiple Inflammatory Contexts: A Systematic Review
- (2019) Vanessa C. D. Bobbo et al. Biomed Research International
- BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer
- (2018) Chun Gong et al. CLINICAL CANCER RESEARCH
- Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines
- (2018) A. Matutino et al. Current Oncology
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
- (2018) Rasmus Siersbæk et al. GENES & DEVELOPMENT
- The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
- (2018) Cesidio Giuliani et al. Frontiers in Endocrinology
- Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
- (2017) Mengmeng Jiang et al. Frontiers in Immunology
- Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
- (2015) Ramona Crescenzo et al. CANCER CELL
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)
- (2015) RONG HU et al. Oncology Letters
- Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells
- (2015) Wei-Hsiu Liu et al. Oncotarget
- Tocilizumab, A Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights
- (2014) Misato Hashizume et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools
- (2014) René Dreos et al. NUCLEIC ACIDS RESEARCH
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer
- (2014) Sandra Van Schaeybroeck et al. Cell Reports
- Emerging roles of the corepressors NCoR1 and SMRT in homeostasis
- (2013) A. Mottis et al. GENES & DEVELOPMENT
- SpliceArray Profiling of Breast Cancer Reveals a Novel Variant of NCOR2/SMRT That Is Associated with Tamoxifen Resistance and Control of ER Transcriptional Activity
- (2012) L. Zhang et al. CANCER RESEARCH
- Transcription factor co-repressors in cancer biology: roles and targeting
- (2010) Sebastiano Battaglia et al. INTERNATIONAL JOURNAL OF CANCER
- The NF- B Family of Transcription Factors and Its Regulation
- (2009) A. Oeckinghaus et al. Cold Spring Harbor Perspectives in Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started